Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients

相似書籍

• Clofarabine plus Low-Dose Cytarabine Followed by Clofarabine plus Low-Dose Cytarabine Alternating with Decitabine in AML Frontline Therapy of Older Patients
  由: Faderl, Stefan, et al.
  出版: (2012)
• Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients ≤60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)
  由: Nazha, Aziz, et al.
  出版: (2013)
• Final Results of a Phase II Trial of Clofarabine and Low-Dose Cytarabine Alternating with Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia
  由: Kadia, Tapan M., et al.
  出版: (2015)
• Prognostic Significance of Alterations in IDH Enzyme Isoforms in Patients With AML Treated With High Dose Cytarabine and Idarubicin
  由: Ravandi, Farhad, et al.
  出版: (2011)
• Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
  由: Boddu, Prajwal, et al.
  出版: (2017)